| アブストラクト | Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18-64 years, >/=65 years) and gender (female, male). Results: There were age and gender disparities among adults with AEs following COVID-19 vaccination. Compared to younger adults aged between 18 and 64 years, older adults were more likely to report serious AEs, death, permanent disability, and hospitalization. Males were more likely to report serious AEs, death, and hospitalization compared to females. Conclusions: COVID-19 vaccines are generally safe but possible age and gender disparities in reported AEs may exist. |
|---|
| ジャーナル名 | Frontiers in medicine |
|---|
| 投稿日 | 2021/8/6 |
|---|
| 投稿者 | Xiong, Xiaomo; Yuan, Jing; Li, Minghui; Jiang, Bin; Lu, Z Kevin |
|---|
| 組織名 | Department of Clinical Pharmacy and Outcomes Sciences, University of South;Carolina, Columbia, SC, United States.;Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai,;China.;Department of Clinical Pharmacy and Translational Science, University of;Tennessee Health Science Center, Memphis, TN, United States.;Department of Administrative and Clinical Pharmacy, School of Pharmaceutical;Sciences, Health Science Center, Peking University, Beijing, China. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/34350199/ |
|---|
